Pharvaris director proposes $29K share sale
The notice lists 65,210,590 common shares outstanding, separate from the proposed 800-share sale.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Pharvaris N.V. (PHVS) director Johannes Gerardus Christiaan Petrus Schikan reported a proposed sale of 800 common shares, with an aggregate market value of $28,952.00 and an approximate sale date of September 22, 2026. He acquired the shares that day by exercising options under a registered plan and paying cash.
The notice also lists four sales during the past three months, including 200,000 shares sold on September 17, 2026, for gross proceeds of $7,000,000.00.
Key Figures
Key Terms
registered plan financial
Aggregate Market Value financial
Gross Proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What prior sales did the PHVS director report?
AI-generated analysis. How Rhea-AI works. Not financial advice.